Search for:
Author

Jane Hobson

Browsing
Jane E. Hobson is a partner in Baker Mckenzie's London office. She works in the Firm's London Corporate group, is a member of the Global M&A Practice Group, and focuses on cross-border mergers and acquisitions, licensing transactions and joint ventures in the pharmaceutical and healthcare sector.

Click to read Digital healthcare, a globally booming market, has been catalyzed by the events of COVID-19. In Asia Pacific, in particular, a rapidly expanding population, an empowered and tech-savvy middle class and physician shortage has created the perfect conditions for digital health innovation. A new era of digital healthcare…

With the healthcare and life sciences sector at the heart of the pandemic, we are seeing some new issues arising in the already complex world of life sciences collaborations, for both coronavirus-related and other products and therapies. The Life Sciences Collaborations: Key Considerations in the COVID-19 Era document is a…

Healthcare and life sciences is a robust market. Though it’s not immune to the economic and geopolitical headwinds affecting all industries, its underlying strength will continue to promote dealmaking. Following a robust 2018, dealmaking activity in the sector softened in 2019. Our Global Transactions Forecast, compiled in collaboration with Oxford Economics,…